
ADMA Biologics Inc (ADMA)
US$ 20.192.54%
Price Chart
Key Statistics
Market Cap
$ 4.82B
P/E Ratio
24.04
Revenue (TTM)
$ 459.38M
Volume
2.4M
52W High
$ 25.67
52W Low
$ 9.31
Dividend Yield
0.00%
Beta
0.57
Technicals
50-Day MA
20.3358
200-Day MA
18.3241
52 Week High
25.67
52 Week Low
9.3101
About ADMA
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United.
Employees
685
Headquarters
Ramsey, NJ
CEO
Mr. Adam S. Grossman
Latest News
Should ADMA Biologics Stock Be in Your Portfolio Pre-Q1 Earnings? - Yahoo Finance
3 weeks ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg